Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE-3 protein in patients with detectable metastatic melanoma.

Details

Language :

English

ISSN :

00207136

Volume :

117

Issue :

4

Database :

Complementary Index

Journal :

International Journal of Cancer

Publication Type :

Academic Journal

Accession number :

62207500

Full Text :

https://doi.org/10.1002/ijc.21264